Sign in
4

Changes in Ownership

Axogen, Inc. Filed Acc 0000805928-22-000034

Chief R&D Officer gave up 2,770 shares (to pay taxes)

  • Chief R&D Officer acquired 11,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Scopelianos Angelo · Chief R&D Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-03-16 Exercise or conversion : show line 1 in the form +11,000 22,950 D
2022-03-16 Shares withheld for taxes : show line 2 in the form −2,770 $7.97 $22,077 20,180 D

Table II: Derivative

3 lines
Date Transaction Shares Owned after D/I
2022-03-16 Exercise or conversion : show line 3 in the form Restricted Stock Units −11,000 11,000 D
2022-03-16 Grant or award : show line 4 in the form Restricted Stock Units +42,563 42,563 D
2022-03-16 Grant or award : show line 5 in the form Employee Stock Option (right to purchase) +39,700 39,700 D
Loading xslF345X03/wf-form4_164763424502227.xml…